Clinical and immunologic differences in cellulitis vs. pseudocellulitis

References

• Raff AB, Kroshinsky D. Cellulitis a review. J Am Med Assoc. 2016;316(3):325–337.
   PubMed Web of Science ®Google Scholar
• Zhang M, Markova A, Harp J, et al. Dermatology-specific and all-cause 30-day and calendar-year readmissions and costs for dermatologic diseases from 2010-2014. J Am Acad Dermatol. 2019;81(3):740–748.
   PubMed Web of Science ®Google Scholar
• RA P, LA P, JE C, et al. Increasing incidence, cost, and seasonality in patients hospitalized for cellulitis. Open Forum Infect Dis. 2017;4(1):1–4.
   Web of Science ®Google Scholar
• Kroshinsky. The growing problem of pseudocellulitis. The dermatologist. 2014;22(11):1.
   Google Scholar
• Ly N, Goldenberg M, Korman AM, et al. A retrospective study of cellulitis outcomes in Ohio hospitals with or without access to dermatology residency programs. Int J Dermatol. 2021 Apr 26. Epub ahead of print. PMID: 33900621. DOI:https://doi.org/10.1111/ijd.15611
   Google Scholar
• Levell NJ, Wingfield CG, Garioch JJ. Severe lower limb cellulitis is best diagnosed by dermatologists and managed with shared care between primary and secondary care. Br J Dermatol. 2011;164(6):1326–1328.
   PubMedGoogle Scholar
• Alexandra W, Gupta P, Tian F, et al. The effect of implementing teledermatology in patients presenting with cellulitis versus pseudocellulitis in an academic emergency department setting: a pilot study. J Clin Aesthet Dermatol. 2020;13(4):43–44.
   PubMedGoogle Scholar
• Li DG, Di XF, Khosravi H, et al. Outcomes of early dermatology consultation for inpatients diagnosed with cellulitis. JAMA Dermatol. 2018;02115:1–7.
   Google Scholar
• Gunderson CG, Cherry BM, Fisher A. Do patients with cellulitis need to be hospitalized? A systematic review and meta-analysis of mortality rates of inpatients with cellulitis. J Gen Intern Med. 2018;33(9):1553–1560.
   PubMed Web of Science ®Google Scholar
• Raya-Cruz M, Payeras-Cifre A, Ventayol-Aguiló L, et al. Factors associated with readmission and mortality in adult patients with skin and soft tissue infections. Int J Dermatol. 2019;58(8):916–924.
   PubMed Web of Science ®Google Scholar
• Macía-Rodríguez C, Alende-Castro V, Vazquez-Ledo L, et al. Skin and soft-tissue infections: factors associated with mortality and re-admissions. Enfermedades Infecc y Microbiol Clin (English ed). 2017;35(2):76–81.
   Google Scholar
• Halilovic J, Heintz BH, Brown J. Risk factors for clinical failure in patients hospitalized with cellulitis and cutaneous abscess. J Infect. 2012;65(2):128–134.
   PubMed Web of Science ®Google Scholar
• Figtree M, Konecny P, Jennings Z, et al. Risk stratification and outcome of cellulitis admitted to hospital. J Infect. 2010;60(6):431–439.
   PubMed Web of Science ®Google Scholar
• Kilburn SA, Featherstone P, Higgins B, et al. Interventions for cellulitis and erysipelas. Cochrane Database Syst Rev 2010;6 : No.:CD004299.9. DOI: https://doi.org/10.1002/14651858.CD004299.pu. doi:10.1002/14651858.cd004299.pub2: . DOI: .
   Google Scholar
• Cross ELA, Jordan H, Godfrey R, et al. Route and duration of antibiotic therapy in acute cellulitis: a systematic review and meta-analysis of the effectiveness and harms of antibiotic treatment. J Infect. 2020;81(4):521–531.
   PubMed Web of Science ®Google Scholar
• Yuxin E, Mrcp T, Fook-chong S, et al. Cellulitis recurrence score: a tool for predicting recurrence of lower limb cellulitis. J Am Dermatology. 2014;72(1):140–145.
   Google Scholar
• Garg A, Lavian J, Lin G, et al. Clinical factors associated with readmission among patients with lower limb cellulitis. Dermatology. 2017;233(1):58–63.
   PubMed Web of Science ®Google Scholar
• Methicillin-Resistant Staphylococcus aureus Skin or Soft Tissue Infections in a State Prison — Mississippi. MMWR. 2000:2001(50):919–922.
   PubMedGoogle Scholar
• Haysom L, Cross M, Anastasas R, et al. Risk factors for Methicillin-Resistant Staphylococcus aureus (MRSA) infections in custodial populations: a systematic review. J Correct Heal Care. 2018;24(2):197–213.
   PubMed Web of Science ®Google Scholar
• Mullen LA, O’Keefe C. Management of skin and soft tissue infections in a county correctional center: a quality improvement project. J Correct Heal Care. 2015;21(4):355–364.
   PubMed Web of Science ®Google Scholar
• David MZ, Mennella C, Mansour M, et al. Predominance of methicillin-resistant staphylococcus aureus among pathogens causing skin and soft tissue infections in a large urban jail: risk factors and recurrence rates. J Clin Microbiol. 2008;46(10):3222–3227.
   PubMed Web of Science ®Google Scholar
• Hota B. Community-associated methicillin-resistant staphylococcus aureus skin and soft tissue infections at a public hospital. Arch Intern Med. 2007;167(10):1026–1033.
   PubMedGoogle Scholar
• Ray GT, Suaya JA, Baxter R. Incidence, microbiology, and patient characteristics of skin and soft-tissue infections in a U.S. population: a retrospective population-based study. BMC Infect Dis. 2013;13(1):1.
   PubMedGoogle Scholar
• Doern GV, Jones RN, Pfaller MA, et al. Bacterial pathogens isolated from patients with skin and soft tissue infections: frequency of occurrence and antimicrobial susceptibility patterns from the SENTRY antimicrobial surveillance program (United States and Canada, 1997. Diagn Microbiol Infect Dis. 1999;34(1):65–72.
   PubMed Web of Science ®Google Scholar
• Duvanel T. Quantitative cultures of biopsy specimens from cutaneous cellulitis. Arch Intern Med. 1989;149(2):293–296.
   PubMedGoogle Scholar
• Hook EW. Microbiologic evaluation of cutaneous cellulitis in adults. Arch Intern Med. 1986;146(2):295–297.
   PubMedGoogle Scholar
• Lee PC, Turnidge J, McDonald PJ. Fine-needle aspiration biopsy in diagnosis of soft tissue infections. J Clin Microbiol. 1985;22(1):80–83.
   PubMed Web of Science ®Google Scholar
• Eron LJ, Lipsky BA. Use of cultures in cellulitis: when, how, and why? Eur J Clin Microbiol Infect Dis. 2006;25(10):615–617.
   PubMedGoogle Scholar
• LJ E, JA B, Medical KM. Cellulitis and the role of the clinical microbiology laboratory. Clin Microbiol Newsl. 2007;29(20):151–158.
   Google Scholar
• Johnson K, Kiyatkin D, An A, et al. PCR offers no advantage over culture for microbiologic diagnosis in cellulitis. Infection. 2012;40(5):537–541.
   PubMed Web of Science ®Google Scholar
• Bruun T, Oppegaard O, Kittang BR, et al. Etiology of cellulitis and clinical prediction of streptococcal disease: a prospective study. Open Forum Infect Dis. 2016;3(1):1–9.
   Web of Science ®Google Scholar
• Peralta G, Padrón E, Roiz MP, et al. Risk factors for bacteremia in patients with limb cellulitis. Eur J Clin Microbiol Infect Dis. 2006;25(10):619–626.
   PubMedGoogle Scholar
• Korniyenko A, Lozada J, Ranade A, et al. Recurrent lower extremity pseudocellulitis. Am J Ther. 2012 Jul;19(4):e141–2. . PMID: 22772033.
   PubMed Web of Science ®Google Scholar
• DR C, APM L, JM P, et al. Cellulitis: current insights into pathophysiology and clinical management. Neth J Med. 2017 Nov;75(9):366–378. PMID: 29219814.
   PubMed Web of Science ®Google Scholar
• Drerup C, Eveslage M, Sunderkoetter C, et al. Diagnostic value of laboratory parameters for the discrimination between erysipelas and limited cellulitis. J Dtsch Dermatol Ges. 2020 Dec;18(12):1417–1424. . Epub 2020 Oct 9. PMID: 33035396.
   Web of Science ®Google Scholar
• Stulberg DL, Penrod MA, Blatny RA. Common bacterial skin infections. Am Fam Physician. 2002 Jul;66(1):119–125.
   PubMed Web of Science ®Google Scholar
• Blumberg G, Long B, Koyfman A. Clinical mimics: an emergency medicine-focused review of cellulitis mimics. J Emerg Med. 2017 Oct;53(4):475–484. PMID: 29079067.
   PubMed Web of Science ®Google Scholar
• Hook EW. 3rd. Acute cellulitis. Arch Dermatol. 1987;123(4):460–461.
   PubMedGoogle Scholar
• Sattar H. Fundamentals of pathology: medical course and step 1 review. Chicago: Pathoma LLC; 2013.
   Google Scholar
• Cranendonk DR, Hugenholtz F, Prins JM, et al. The skin microbiota in patients hospitalized for cellulitis and association with outcome. Clinl Infect Dis. 2019 April 15;68(8):1292–1299. .
   PubMed Web of Science ®Google Scholar
• RC J, MW E, CD S, et al. Bacterial etiology and risk factors associated with cellulitis and purulent skin abscesses in military trainees. PLoS One. 2016 Oct 25;11(10):e0165491. . PMID: 27780238; PMCID: PMC5079656.
   PubMed Web of Science ®Google Scholar
• Douglass J, Graves P, Gordon S. Self-care for management of secondary lymphedema: a systematic review. PLoS Negl Trop Dis. 2016 Jun 8;10(6):e0004740. . PMID: 27275844; PMCID: PMC4898789.
   PubMed Web of Science ®Google Scholar
• Shikino K, Ikusaka M. Primary lymphoedema. BMJ Case Rep. 2018:bcr2018225843. PMID: 30061138; PMCID: PMC6067322. [Jul 30]. https://doi.org/10.1136/bcr-2018-225843
   Google Scholar
• EM M, TH M, LB P, et al. Acute inflammatory edema: a mimicker of cellulitis in critically ill patients. J Am Acad Dermatol. 2019 Oct;81(4):931–936. . Epub 2019 Jun 1. PMID: 31163234
   PubMed Web of Science ®Google Scholar
• Jiang X, Tian W, Granucci EJ, et al. Decreased lymphatic HIF-2α accentuates lymphatic remodeling in lymphedema. J Clin Invest. 2020 Oct 1;130(10):5562–5575. . PMID: 32673288; PMCID: PMC7524470.
   PubMed Web of Science ®Google Scholar
• Bami H, Goodman C, Boldt G, et al. Gemcitabine-induced pseudocellulitis: a case report and review of the literature. Curr Oncol. 2019 Oct;26(5):e703–e706. . Epub 2019 Oct 1. PMID: 31708665; PMCID: PMC6821114.
   PubMed Web of Science ®Google Scholar
• Cosmi B. Management of superficial vein thrombosis. J Thromb Haemost. 2015 Jul;13(7):1175–1183. . Epub 2015 May 25. PMID: 25903684.
   PubMed Web of Science ®Google Scholar
• Tian F, Mazurek KR, Malinak RN, et al. Pseudocellulitis need not be benign: three cases of superficial migratory thrombophlebitis with “negative” venous duplex ultrasonography. j clin aesthet dermatol. 2017 Dec;10(12):49–51. Epub 2017 Dec 1. PMID: 29399267; PMCID: PMC5774904.
   PubMedGoogle Scholar
• Nicklas JM, Gordon AE, Henke PK. Resolution of deep venous thrombosis: proposed immune paradigms. Int J Mol Sci. 2020 Mar 18;21(6):2080. PMID: 32197363; PMCID: PMC7139924.
   Web of Science ®Google Scholar
• Nassau S, Fonacier L. Allergic contact dermatitis. Med Clin North Am. 2020 Jan;104(1):61–76. . Epub 2019 Oct 28. PMID: 31757238.
   PubMed Web of Science ®Google Scholar
• MG A, JP T, Wennervaldt M, et al. Nickel allergy and allergic contact dermatitis: a clinical review of immunology, epidemiology, exposure, and treatment. Contact. Dermatitis. 2019 Oct;81(4):227–241. . Epub 2019 Jul 9. PMID: 31140194
   Web of Science ®Google Scholar
• Batista M, Gonçalo M. The rash that presents as a red swollen face. Clin Dermatol. 2020 Jan-Feb;38(1):63–78. . Epub 2019 Oct 23. PMID: 32197750.
   PubMed Web of Science ®Google Scholar
• Räßler F, Lukács J, Elsner P. Treatment of eosinophilic cellulitis (Wells syndrome) - a systematic review. J Eur Acad Dermatol Venereol. 2016 Sep;30(9):1465–1479. . Epub 2016 Jun 29. PMID: 27357601.
   PubMed Web of Science ®Google Scholar
• Jorizzo J, White WL, Zanolli MD, et al. Sclerosing panniculitis: a clinicopathologic assessment. Arch Dermatol. 1991;127:554–558.
   PubMedGoogle Scholar
• Porter J, Moneta GL. Reporting standards in venous disease: an update. International consensus committee on chronic venous disease. J Vasc Surg. 1995;21:635–645.
   PubMed Web of Science ®Google Scholar
• Miteva M, Romanelli P, Kirsner RS. Lipodermatosclerosis. Dermatol Ther. 2010 Jul-Aug;23(4):375–388. . PMID: 20666825
   PubMed Web of Science ®Google Scholar
• Shiman MI, Pieper B, Templin TN, et al. Venous ulcers: a reappraisal analyzing the effects of neuropathy, muscle involvement, and range of motion upon gait and calf muscle function. Wound Repair Regen. 2009;17(2):147–152.
   Google Scholar
• Falanga V, Moosa HH, Nemeth AJ, et al. Dermal pericapillary fibrin in venous disease and venous ulceration. Arch Dermatol. 1987;123:620–623.
   PubMedGoogle Scholar
• Bergan J, Jolla L. Molecular mechanisms in chronic venous insufficiency. Ann Vasc Surg. 2007;21:260–266.
   PubMed Web of Science ®Google Scholar
• Schmid-Schonbein G, Takase S, Bergan JJ. New advance in the understanding of the pathophysiology of chronic venous insufficiency. Angiology. 2001;52:27–34.
   Web of Science ®Google Scholar
• Azaceta G, Romero S, Moreno JA, et al. Hemorheological profile in chronic insufficiency after surgery. Hemostasis. 1999;29:219–224.
   PubMedGoogle Scholar
• Nicolaides A. Chronic venous disease and the leukocyteendothelium interaction: from symptoms to ulceration. Angiology. 2005;56:S11–S19.
   PubMed Web of Science ®Google Scholar
• Herouy Y, May AE, Pornschlegel G, et al. Lipodermatosclerosis is characterized by elevated expression and activation on matrix metalloproteinases: implications for venous ulcer formation. J Invest Dermatol. 1998;111:822–827.
   PubMed Web of Science ®Google Scholar
• Herouy Y, Aizpuurua J, Stetter C, et al. The role of the urokinase-type plasminogen activator (uPA) and its receptor (CD87).
   Google Scholar
• Higley H, Ksander GA, Gerhardt CO, et al. Extravasation of macromolecules and possible trapping of transforming growth factor-beta in venous ulceration. Br J Dermatol. 1995;132:79.
   PubMed Web of Science ®Google Scholar
• Pappas P, You R, Rameshwar P, et al. Dermal tissue fibrosis in patients with chronic venous insufficiency is associated with increased transforming growth factor – beta 1 gene expression and protein production. J Vasc Surg. 1999;30:1129–1145.
   PubMed Web of Science ®Google Scholar
• Knipper JA, Willenborg S, Brinckmann J, et al. Interleukin-4 receptor α signaling in myeloid cells controls collagen fibril assembly in skin repair. Immunity. 2015 Oct 20;43(4):803–816. . PMID: 26474656; PMCID: PMC4681399.
   PubMed Web of Science ®Google Scholar
• Stacey M, Burnand KG, Bhogal BS, et al. Pericapillary fibrin deposits and skin hypoxia precede the changes of lipodermatosclerosis in limbs at increased risk of developing venous ulcer. Cardiovasc Surg. 2000;8(5):372–380.
   PubMedGoogle Scholar
• Schmeller W, Roszinski S, Huesmann M. Tissue oxygenation and microcirculation in dermatoliposclerosis with different degrees of erythema at the margins of venous ulcers: a contribution to hypodermitis symptoms. Vasa. 1997;26:18–24.
   PubMedGoogle Scholar
• Falanga V, Bontempo FA, Eaglestein WH. Protein C and protein S plasma levels in patients with lipodermatosclerosis and venous ulcers. Arch Dermatol. 1990;126:1195–1197.
   PubMedGoogle Scholar
• Protein SC. C and protein S plasma levels in patients with lipodermatosclerosis and venous ulceration. Arch Dermatol. 1991;127:908–909.
   PubMedGoogle Scholar
• Leu A, Leu HJ, Franzeck UK, et al. Morphology of chronic venous insufficiency – light and electron microscopic examination. Vasa. 1991;20:330–342.
   PubMedGoogle Scholar
• Bruce A, Bennett D, Lohse CM, et al. Lipodermatosclerosis: review of cases evaluated at mayo clinic. J Am Acad Dermatol. 2002;46:187–192.
   PubMed Web of Science ®Google Scholar
• Hyman DA, Cohen PR. Stasis dermatitis as a complication of recurrent levofloxacin-associated bilateral leg edema. Dermatol Online J. 2013 Nov 15;19(11):20399. PMID: 24314775.
   PubMedGoogle Scholar
• Weis SC, Nguyen J, Chon S, et al. A randomized controlled clinical trial assessing the effect of betamethasone valerate 0.12% foam on the short-term treatment of stasis dermatitis. J Drugs Dermatol. 2005;4: 334–339. PMID: 15898290.
   Google Scholar
• Cicocon JO, Fernandez BB, Cicon DG. Leg edema: clinical cues to a differential diagnosis. Geriatrics. 1993;48: 34–50. PMID: 7695655.
   Web of Science ®Google Scholar
• Bergan JJ, Schmid-Schonbein GW, Smith PD, et al. Chronic venous disease. N Engl J Med. 2006;355: 488–498. PMID: 17653022.
   PubMed Web of Science ®Google Scholar
• Klassen W. Office management of stasis ulcer and stasis dermatitis. Can Fam Phys. 1983;29:279–283.[ PMID: 21283318]
   Google Scholar
• Weaver J, Billings SD. Initial presentation of stasis dermatitis mimicking solitary lesions: a previously unrecognized clinical scenario. J Am Acad Dermatol. 2009;61(1028–1032). PMID: 19925928.
   Google Scholar
• Blake T, Manahan M, Rodins K. Erythema nodosum - a review of an uncommon panniculitis. Dermatol Online J. 2014 Apr 16;20(4):22376. PMID: 24746312.
   PubMedGoogle Scholar
• Gilchrist H, Patterson JW. Erythema nodosum and erythema induratum (nodular vasculitis): diagnosis and management. Dermatol Ther. 2010 Jul-Aug;23(4):320–327. PMID: 20666819.
   PubMed Web of Science ®Google Scholar
• De Simone C, Caldarola G, Scaldaferri F, et al. Clinical, histopathological, and immunological evaluation of a series of patients with erythema nodosum. Int J Dermatol. 2016;55(5):e289–e294.
   PubMed Web of Science ®Google Scholar
• Pérez-Garza DM, Chavez-Alvarez S, Ocampo-Candiani J, et al. Erythema nodosum: a practical approach and diagnostic algorithm. Am J Clin Dermatol. 2021 May;22(3):367–378. . Epub 2021 Mar 8. PMID: 33683567; PMCID: PMC7938036.
   PubMed Web of Science ®Google Scholar
• Labunski S, Posern G, Ludwig S, et al. Tumor necrosis factor-alpha promoter polymorphism in erythema nodosum. Acta Derm Venereol. 2001;81:18–21.
   PubMed Web of Science ®Google Scholar
• Chowaniec M, Starba A, Wiland P. Erythema nodosum - review of the literature. Epub 2016 Jun 3. PMID: 27407284; PMCID: PMC4918048 Reumatologia. 2016;542:79–82.
   PubMedGoogle Scholar
• Verthelyir D. Sex hormones as immunomodulators in health and disease. International Immunopharmacology. 2001;6:983–993.
   Google Scholar
• Demirkesen C, Tuzuner N, Senocak M, et al. Comparative study of adhesion molecule expression in nodular lesions of Behcet syndrome and other forms of panniculitis. Am J Clin Pathol. 2008;130(1):28–33.
   PubMed Web of Science ®Google Scholar
• Akdis AC, Kilicturgay K, Helvaci S, et al. Immunological evaluation of erythema nodosum in tularaemia. Br J Dermatol. 1993;129(3):275–279.
   PubMed Web of Science ®Google Scholar
• Pyo JY, Ha YJ, Song JJ, et al. Delta neutrophil index contributes to the differential diagnosis between acute gout attack and cellulitis within 24 hours after hospitalization. Rheumatology. 2017 May 1;56(5):795–801. . PMID: 28115599.
   PubMed Web of Science ®Google Scholar
• Chen J, Wu M, Yang J, et al. The immunological basis in the pathogenesis of gout. Iran J Immunol. 2017 Jun;14(2):90–98. PMID: 28630380.
   PubMed Web of Science ®Google Scholar
• Dalbeth N, Merriman TR, Stamp LK. Gout. Lancet. 2016 Oct 22;388(10055):2039–2052. . Epub 2016 Apr 21. PMID: 27112094.
   PubMed Web of Science ®Google Scholar
• Martin WJ, Walton M, Harper J. Resident macrophages initiating and driving inflammation in a monosodium urate monohydrate crystal-induced murine peritoneal model of acute gout. Arthritis Rheum. 2009;60:281–289.
   PubMed Web of Science ®Google Scholar
• FS DG, SE M, Thornton E, et al. Urate crystals stimulate production of tumor necrosis factor alpha from human blood monocytes and synovial cells. Cytokine mRNA and protein kinetics, and cellular distribution. J Clin Invest. 1991;87:1375–1381.
   PubMed Web of Science ®Google Scholar
• Liu R, Aupperle K, Terkeltaub R. Src family protein tyrosine kinase signaling mediates monosodium urate crystal-induced IL-8 expression by monocytic THP-1 cells. J Leukoc Biol. 2001;70:961–968.
   PubMed Web of Science ®Google Scholar
• Guerne PA, Terkeltaub R, Zuraw B, et al. Inflammatory microcrystals stimulate interleukin-6 production and secretion by human monocytes and synoviocytes. Arthritis Rheum. 1989;32:1443-52.
   Google Scholar
• Liu-Bryan R. Intracellular innate immunity in gouty arthritis: role of NALP3 inflammasome. Immunol Cell Biol. 2010;88:20–23.
   PubMed Web of Science ®Google Scholar
• Landis RC, Haskard DO. Pathogenesis of crystal-induced inflammation. Curr Rheumatol Rep. 2001;3:36–41.
   PubMedGoogle Scholar
• Rose DM, Liu-Bryan R. Innate immunity in triggering and resolution of acute gouty inflammation. Curr Rheumatol Rep. 2006;8:209–214.
   PubMedGoogle Scholar
• Shi Y, Mucsi AD, Ng G. Monosodium urate crystals in inflammation and immunity. Immunol Rev. 2010;233:203–217.
   PubMed Web of Science ®Google Scholar
• Matsukawa A, Yoshimura T, Maeda T, et al. Analysis of the cytokine network among tumor necrosis factor alpha, interleukin-1beta, interleukin-8, and interleukin-1 receptor antagonist in monosodium urate crystal-induced rabbit arthritis. Lab Invest. 1998;78:559–569.
   PubMed Web of Science ®Google Scholar
• Cronstein BN, Terkeltaub R. The inflammatory process of gout and its treatment. Arthritis Res Ther. 2006;8(1):S3.
   PubMedGoogle Scholar
• Montero-Melendez T, Patel HB, Perretti M. Role of melanocortin receptors in the regulation of gouty inflammation. Curr Rheumatol Rep. 2011;13:138–145.
   PubMed Web of Science ®Google Scholar
• Conforti-Andreoni C, Spreafico R, Qian HL, et al. Uric acid-driven Th17 differentiation requires inflammasome-derived IL-1 and IL-18. J Immunol. 2011;187:5842–5850.
   PubMed Web of Science ®Google Scholar
• Shi Y, Evans JE, Rock KL. Molecular identification of a danger signal that alerts the immune system to dying cells. Nature. 2003;425:516–521.
   PubMed Web of Science ®Google Scholar
• Kanevets U, Sharma K, Dresser K, et al. A role of IgM antibodies in monosodium urate crystal formation and associated adjuvanticity. J Immunol. 2009;182:1912–1918.
   PubMedGoogle Scholar
• Lai S, Zhou X. Inflammatory cells in tissues of gout patients and their correlations with comorbidities. Open Rheumatol J. 2013;7:26–31.
   PubMedGoogle Scholar
• Khodaee M. Common superficial bursitis. Am Fam Physician. 2017 Feb 15;95(4):224–231. PMID: 28290630.
   PubMed Web of Science ®Google Scholar
• Rishor-Olney CR, Pozun A. Prepatellar Bursitis. 2021Feb22. StatPearls [Internet]. Treasure Island (FL). StatPearls Publishing: 2021 Jan. PMID: 32491440
   Google Scholar
• Zimmermann BIII, Mikolich DJ, Jr HG. Septic bursitis. Semin Arthritis Rheum. 1995;24(6):391–410.
   Google Scholar
• Cea-Pereiro JC, Garcia-Meijide J, Mera-Varela A, et al. A comparison between septic bursitis caused by Staphylococcus aureus and those caused by other organisms. Clin Rheumatol. 2001;20(1):10–14.
   PubMed Web of Science ®Google Scholar
• Perez C, Huttner A, Assal M, et al. Infectious olecranon and patellar bursitis: short-course adjuvant antibiotic therapy is not a risk factor for recurrence in adult hospitalized patients. J Antimicrob Chemother. 2010;65(5):1008–1014.
   PubMed Web of Science ®Google Scholar
• Arakaki RY, Strazzula L, Woo E, et al. The impact of dermatology consultation on diagnostic accuracy and antibiotic usage among patients presenting with suspected cellulitis to outpatient internal medicine offices: a randomized-controlled trial. JAMA Dermatol. 2014;150(10):1056–1061.
   PubMed Web of Science ®Google Scholar
• AM K, Kroshinsky D, AB R, et al. Society of dermatology hospitalists scientific task force on cellulitis. A survey-based study of diagnostic and treatment concordance in standardized cases of cellulitis and pseudocellulitis via teledermatology. J Am Acad Dermatol. 2020 May;82(5):1221–1223. . Epub 2019 Oct 15. PMID: 31626887
   PubMed Web of Science ®Google Scholar
• Gupta P, Tolliver S, Zhang M, et al. Impact of dermatology and teledermatology consultations for patients admitted with cellulitis: a pilot study. J Am Acad Dermatol. 2020 Feb;82(2):513–515. . Epub 2019 Sep 23. PMID: 31557497.
   PubMed Web of Science ®Google Scholar
• Kaliyadan F, Ramsey ML. Teledermatology 2020 Oct 12. StatPearls [Internet]. Treasure Island (FL). StatPearls Publishing: 2021Jan. PMID: 29083682
   Google Scholar
• AT Y, Xiong M, Pfau J, et al. Artificial Intelligence in dermatology: a primer. J Invest Dermatol. 2020 Aug;140(8):1504–1512. . Epub 2020 Mar 27. PMID: 32229141
   PubMed Web of Science ®Google Scholar
• Patel M, Lee SI, Akyea RK, et al. A systematic review showing the lack of diagnostic criteria and tools developed for lower-limb cellulitis. Br J Dermatol. 2019 Dec;181(6):1156–1165. . Epub 2019 Jun 28. PMID: 30844076; PMCID: PMC6916392.
   PubMed Web of Science ®Google Scholar
• Raff AB, Weng QY, Cohen JM, et al. A predictive model for diagnosis of lower extremity cellulitis: a cross-sectional study. J Am Acad Dermatol. 2017 Apr;76(4):618–625.e2. . Epub 2017 Feb 16. PMID: 28215446.
   PubMed Web of Science ®Google Scholar